| Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1 Z Hossain, SM Ali, HL Ko, J Xu, CP Ng, K Guo, Z Qi, S Ponniah, W Hong, ... Proceedings of the National Academy of Sciences 104 (5), 1631-1636, 2007 | 337 | 2007 |
| Functional aspects of PARP1 in DNA repair and transcription HL Ko, EC Ren Biomolecules 2 (4), 524-548, 2012 | 228 | 2012 |
| The p53 response element and transcriptional repression B Wang, Z Xiao, HL Ko, EC Ren Cell cycle 9 (5), 870-879, 2010 | 110 | 2010 |
| Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A* 11 J Liu, Z Xiao, HL Ko, M Shen, EC Ren Proceedings of the National Academy of Sciences 111 (7), 2662-2667, 2014 | 107 | 2014 |
| hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors Z Xiao, HL Ko, EH Goh, B Wang, EC Ren Carcinogenesis 34 (7), 1458-1467, 2013 | 58 | 2013 |
| HNF4α combinatorial isoform heterodimers activate distinct gene targets that differ from their corresponding homodimers HL Ko, Z Zhuo, EC Ren Cell reports 26 (10), 2549-2557. e3, 2019 | 52 | 2019 |
| Novel poly (ADP‐ribose) polymerase 1 binding motif in hepatitis B virus core promoter impairs DNA damage repair HL Ko, EC Ren Hepatology 54 (4), 1190-1198, 2011 | 34 | 2011 |
| Identification of Slug and SOX7 as transcriptional repressors binding to the hepatitis B virus core promoter HL Ko, TH Lam, H Ng, J Toh, LW Wang, EC Ren Journal of hepatology 68 (1), 42-52, 2018 | 14 | 2018 |
| How far along are we in revealing the connection between metformin and colorectal cancer? MC Berkovic, D Mikulic, I Bilic-Curcic, A Mrzljak World journal of gastroenterology 27 (14), 1362, 2021 | 13 | 2021 |
| Functional aspects of PARP1 in DNA repair and transcription. Biomolecules 2, 524–548 HL Ko, EC Ren, HL Ko, EC Ren | 9 | 2012 |
| Reduced ADP‐ribosylation by PARP 1 natural polymorphism V762A and by PARP 1 inhibitors enhance Hepatitis B virus replication HL Ko, HJ Ng, EH Goh, EC Ren Journal of Viral Hepatitis 20 (9), 658-665, 2013 | 8 | 2013 |
| Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B ZY Goh, EC Ren, HL Ko World journal of gastroenterology 27 (14), 1369, 2021 | 6 | 2021 |
| Functional aspects of PARP1 in DNA repair and transcription. Biomolecules. 2012; 2 (4): 524-48 HL Ko, EC Ren PubMed Abstract| Publisher Full Text| Free Full Text, 0 | 5 | |
| Functional aspects of PARP1 in DNA repair and transcription. Biomolecules, 2012, 2 (4), 524-548 HL Ko, EC Ren | 5 | |
| Parp-1 inhibitors EC Ren, HL Ko US Patent App. 13/877,972, 2014 | 1 | 2014 |
| p53 B Wang, Z Xiao, HL Ko, EC Ren Cell Cycle, 2010 | 1 | 2010 |
| Functional Analysis of a Novel HNF4A Variant Identified in a Patient With MODY1 S Morikawa, HL Ko, EC Ren, K Hara, N Kaneko, N Hishimura, ... Journal of the Endocrine Society 8 (6), bvae090, 2024 | | 2024 |
| cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels EC Ren, NZ Zhuo, ZY Goh, I Bonne, B Malleret, HL Ko Biomolecules 13 (10), 1438, 2023 | | 2023 |
| Enhanced cell based screening platform for anti-hbv therapeutics EC Ren, HL Ko US Patent App. 17/423,010, 2022 | | 2022 |
| Parp-1 inhibitors EC Ren, HL KO | | 2013 |
